Related Experiment Video
Updated: Jun 29, 2026
18:30
Rat Mesentery Angiogenesis Assay
Published on: June 18, 2011
Leukemia inhibitory factor (LIF) inhibits angiogenesis in vitro
M S Pepper1, N Ferrara, L Orci
1Department of Morphology, University Medical Center, Geneva, Switzerland.
Journal of Cell Science
|January 1, 1995
Summary
Leukemia inhibitory factor (LIF) inhibits angiogenesis, the formation of new blood vessels, in laboratory settings. LIF reduces endothelial cell proliferation, migration, and extracellular proteolysis, key processes in blood vessel development.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Angiogenesis is crucial for development and disease.
- Leukemia inhibitory factor (LIF) is a cytokine with diverse biological roles.
- Understanding LIF's role in angiogenesis is important for therapeutic development.
Purpose of the Study:
- To investigate the effect of leukemia inhibitory factor (LIF) on angiogenesis in vitro.
- To determine the mechanisms by which LIF influences endothelial cell behavior.
Main Methods:
- Utilized an in vitro model of angiogenesis using endothelial cells in a three-dimensional collagen gel.
- Assessed endothelial cell proliferation, migration, and proteolytic activity.
- Examined the expression of plasminogen activator inhibitor-1.
Main Results:
- Leukemia inhibitory factor (LIF) significantly inhibited capillary-like tube formation in vitro.
- LIF reduced endothelial cell proliferation induced by basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF).
- LIF decreased endothelial cell migration and proteolytic activity, while increasing plasminogen activator inhibitor-1 expression.
Conclusions:
- Leukemia inhibitory factor (LIF) acts as an inhibitor of angiogenesis in vitro.
- LIF's anti-angiogenic effects are mediated by reduced endothelial cell proliferation, migration, and extracellular proteolysis.
Related Concept Videos
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...